Aortic Uptake of 18F-NaF and 18F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy.

IF 7.4 1区 医学 Q1 HEMATOLOGY
Takehiro Nakahara, Raita Miyazawa, Yu Iwabuchi, Kai Tonda, Nupoor Narula, H William Strauss, Jagat Narula, Masahiro Jinzaki
{"title":"Aortic Uptake of <sup>18</sup>F-NaF and <sup>18</sup>F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy.","authors":"Takehiro Nakahara, Raita Miyazawa, Yu Iwabuchi, Kai Tonda, Nupoor Narula, H William Strauss, Jagat Narula, Masahiro Jinzaki","doi":"10.1161/ATVBAHA.124.321110","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of <sup>18</sup>F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake was predictive of abdominal aortic aneurysm expansion.</p><p><strong>Methods: </strong>Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography-computed tomography with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl<sub>2</sub> or saline stimulation. In the 1-week cohort (n=25), the correlation between <sup>18</sup>F-FDG or <sup>18</sup>F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake or calcification volume was examined.</p><p><strong>Results: </strong>In the 1-week cohort, the maximum standard unit value of <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake correlated with CD68- (r=0.82; <i>P</i>=0.001) and von Kossa staining-positive areas (r=0.89; <i>P</i><0.001), respectively. In the time course cohort, <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, <sup>18</sup>F-FDG showed high uptake at weeks 1 and 2, whereas a high <sup>18</sup>F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake and calcification volume, especially at 1 and 2 weeks (<sup>18</sup>F-NaF [1 week]: r=0.61, <sup>18</sup>F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; <i>P</i><0.001). Multiple linear regression analysis showed that the combination of these factors predicted the final aortic size, with <sup>18</sup>F-NaF uptake at 1 week being the strongest predictor.</p><p><strong>Conclusions: </strong>The uptake of <sup>18</sup>F-NaF and <sup>18</sup>F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with <sup>18</sup>F-NaF uptake being the strongest predictor.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":null,"pages":null},"PeriodicalIF":7.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.124.321110","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of 18F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether 18F-FDG and 18F-NaF uptake was predictive of abdominal aortic aneurysm expansion.

Methods: Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography-computed tomography with 18F-FDG and 18F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl2 or saline stimulation. In the 1-week cohort (n=25), the correlation between 18F-FDG or 18F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential 18F-FDG and 18F-NaF uptake or calcification volume was examined.

Results: In the 1-week cohort, the maximum standard unit value of 18F-FDG and 18F-NaF uptake correlated with CD68- (r=0.82; P=0.001) and von Kossa staining-positive areas (r=0.89; P<0.001), respectively. In the time course cohort, 18F-FDG and 18F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, 18F-FDG showed high uptake at weeks 1 and 2, whereas a high 18F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with 18F-FDG and 18F-NaF uptake and calcification volume, especially at 1 and 2 weeks (18F-NaF [1 week]: r=0.61, 18F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; P<0.001). Multiple linear regression analysis showed that the combination of these factors predicted the final aortic size, with 18F-NaF uptake at 1 week being the strongest predictor.

Conclusions: The uptake of 18F-NaF and 18F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with 18F-NaF uptake being the strongest predictor.

主动脉对 18F-NaF 和 18F-FDG 的摄取及钙化可预测腹主动脉瘤的发展,并可通过药物治疗减弱。
背景:腹主动脉瘤会随着时间的推移而扩大,并增加致命破裂的风险。为了预测动脉瘤的扩张,有人研究了单独评估动脉瘤中 18F- 氟脱氧葡萄糖(FDG)和氟化钠(NaF)摄取量或钙化体积的方法,但结果各不相同。我们系统地评估了 18F-FDG 和 18F-NaF 摄取量是否能预测腹主动脉瘤的扩张:74只雄性Sprague-Dawley大鼠腹主动脉瘤模型在CaCl2或生理盐水刺激后1、2、4、6和8周时接受了18F-FDG和18F-NaF正电子发射计算机断层扫描成像。在 1 周队列(25 人)中,研究了 18F-FDG 或 18F-NaF 摄取与病理标记物之间的相关性。在时间进程队列(n=49)中,动物接受了阿托伐他汀、洛沙坦、阿达通或利塞膦酸钠,以评估这些药物的作用,并研究了主动脉大小与18F-FDG和18F-NaF摄取量或钙化体积之间的关系:结果:在1周的队列中,18F-FDG和18F-NaF摄取量的最大标准单位值与CD68阳性区域(r=0.82;P=0.001)和von Kossa染色阳性区域(r=0.89;P18F-FDG和18F-NaF摄取量的变化与时间有关,药物会减弱这种摄取量。具体来说,18F-FDG 在第 1 周和第 2 周的摄取量较高,而 18F-NaF 在整个研究期间的摄取量较高。阿托伐他汀和利塞膦酸钠分别显示主动脉面积减小和增大。最终主动脉面积与18F-FDG和18F-NaF摄取量及钙化体积密切相关,尤其是在1周和2周时(18F-NaF[1周]:r=0.61,18F-FDG[2周]:r=0.51,钙化体积[1周]:r=0.59;1周时的P18F-NaF摄取量是最强的预测指标:结论:18F-NaF和18F-FDG摄取量以及钙化体积在适当时间与腹主动脉瘤的发展相关,其中18F-NaF摄取量是最强的预测指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信